A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study
Titel:
A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study
Auteur:
Monk, B.J. Brady, M.F. Aghajanian, C. Lankes, H.A. Rizack, T. Leach, J. Fowler, J.M. Higgins, R. Hanjani, P. Morgan, M. Edwards, R. Bradley, W. Kolevska, T. Foukas, P. Swisher, E.M. Anderson, K.S. Gottardo, R. Bryan, J.K. Newkirk, M. Manjarrez, K.L. Mannel, R.S. Hershberg, R.M. Coukos, G.